医学
前列腺癌
雄激素剥夺疗法
安慰剂
恩扎鲁胺
雄激素受体
抗雄激素
内科学
雄激素
肿瘤科
泌尿科
癌症
阉割
病理
激素
替代医学
作者
Kim N.,Neeraj Agarwal,Anders Bjartell,Byung Ha Chung,Andrea Juliana Gomes,Robert Given,Álvaro Juárez Soto,Axel S. Merseburger,Mustafa Özgüroğlu,Hirotsugu Uemura,Dingwei Ye,Kris Deprince,Vahid Naini,Jinhui Li,Shinta Cheng,Margaret K. Yu,Ke Zhang,Julie S. Larsen,Sharon McCarthy,Simon Chowdhury
标识
DOI：10.1056/nejmoa1903307
摘要
Apalutamide is an inhibitor of the ligand-binding domain of the androgen receptor. Whether the addition of apalutamide to androgen-deprivation therapy (ADT) would prolong radiographic progression–free survival and overall survival as compared with placebo plus ADT among patients with metastatic, castration-sensitive prostate cancer has not been determined.
科研通智能强力驱动
Strongly Powered by AbleSci AI
PDF的下载单位、IP信息已删除
浮游
哆啦的空间站
GingerF
zcl
昏睡的蟠桃
子车茗
eric888
小青椒
聪慧的正豪
不配.
changping
tuanheqi
打工小房
Criminology34
有结果
star
无极微光
yznfly
LaTeXer
冬雪丶消融
雨0926
彭于彦祖
GPTea
七月流火
Dean
ldkl
yangjiafengzi
馆长
皖公网安备34019202002308
